Immune cells are an ally, not enemy, in battle against Alzheimer's

January 29, 2015 by Bill Hathaway
Immune cells are an ally, not enemy, in battle against Alzheimer’s
The cell in green is a microglia, an immune system cell that is blocking free floating beta amyloid (in red) as it binds to amyloid plaque (blue), the hallmark of Alzheimer’s Disease. Yale researchers found that rather than a marker for damaging inflammation, these cells protect the brain from free floating amyloid.

Beta-amyloid is a sticky protein that aggregates and forms small plaques in the brains of the elderly and is thought to be a cause of Alzheimer's disease. Because specialized immune cells always surround these plaques, many have theorized that these cells are responsible for inflammation and damage to surrounding brain cells.

That theory appears to be wrong, according to a new study by Yale School of Medicine researchers published in the Jan. 29 issue of Nature Communications. Instead of causing damage, these brain —called microglia—seem to protect the brain by keeping corralled, the paper shows.

Previous research had shown that some people with large accumulations of plaques do not necessarily have symptoms of dementia, which led researchers to search for other causes of . Inflammation was one of potential culprits identified by scientists. However Alzheimer's drugs that target inflammation in the brain have failed to show any benefit.

"The idea that is always bad is a simplistic view and is probably wrong when talking about Alzheimer's," said Jaime Grutzendler, associate professor in the Department of Neurology and senior author of the study. "In fact, as we age we lose microglia and become less able to confine plaques, leading to the release of plaque toxins that destroy the connections between neurons."

The new study using high-resolution imaging technology revealed that in the brains of mice, microglia actually act as a physical barrier that slows the expansion of plaques and blocks the ability of free-floating beta-amyloid proteins to bind to the plaques and cause toxicity.

"One possibility is that microglia nicely insulate the rest of the brain from plaques and may explain why some people with them do not experience severe cognitive decline," Grutzendler said. "By improving microglia's shielding function, we were able to reduce toxicity to neurons."

This insight could lead to new treatments for the disease, he added.

Explore further: In elderly, hardening of arteries linked to plaques in brain

Related Stories

In elderly, hardening of arteries linked to plaques in brain

October 16, 2013
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published ...

Clue to cause of Alzheimer's dementia found in brain samples

October 22, 2012
Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize ...

Suppressing protein may stem Alzheimer's disease process

April 25, 2013
Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer's disease. It's based on unclogging removal of toxic debris that ...

New findings on the brain's immune cells during Alzheimer's disease progression

April 11, 2013
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one hundred years ago. But until today it still ...

Protein that rouses the brain from sleep may be target for Alzheimer's prevention

November 24, 2014
A protein that stimulates the brain to awaken from sleep may be a target for preventing Alzheimer's disease, a study by researchers at Washington University School of Medicine in St. Louis suggests.

Recommended for you

Researchers reveal new details on aged brain, Alzheimer's and dementia

November 21, 2017
In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that ...

Dementia study sheds light on how damage spreads through brain

November 20, 2017
Insights into how a key chemical disrupts brain cells in a common type of dementia have been revealed by scientists.

Study shows video games could cut dementia risk in seniors

November 16, 2017
Could playing video games help keep the brain agile as we age?

New player in Alzheimer's disease pathogenesis identified

November 14, 2017
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check. The study, published in Nature Communications, ...

Biomarker may predict early Alzheimer's disease

November 10, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery, published in Nature Communications, may ...

Smell test challenge suggests clinical benefit for some before development of Alzheimer's

November 10, 2017
Researchers at Columbia University Medical Center (CUMC) and the New York State Psychiatric Institute (NYSPI) may have discovered a way to use a patient's sense of smell to treat Alzheimer's disease before it ever develops. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.